Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model

Files in this item

This item appears in the following Collection(s)

Available in accordance with the Publisher Policy. Please refer to the publisher's site for terms of use.

Search Repository

My Account